Neuroone Medical Technologies (NMTC) Gross Profit (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.94% |
| Dec 31, 2025 | 2.56% |
| Sep 30, 2025 | 67.09% |
| Jun 30, 2025 | 18.65% |
| Mar 31, 2025 | -59.98% |
| Dec 31, 2024 | 1,265.99% |
| Sep 30, 2024 | -49.96% |
| Jun 30, 2024 | -27.80% |
| Mar 31, 2024 | 46.60% |
| Dec 31, 2023 | 37.52% |
| Sep 30, 2023 | -20.52% |
| Jun 30, 2023 | 673.47% |
| Mar 31, 2023 | 355.98% |
| Dec 31, 2022 | 18.29% |
| Sep 30, 2022 | -134.87% |
| Jun 30, 2022 | 82.30% |
| Mar 31, 2022 | -176.60% |
| Dec 31, 2021 | 23.55% |
| Sep 30, 2021 | 21.56% |
| Jun 30, 2021 | -3.39% |
| Mar 31, 2021 | 43.91% |
| Jun 30, 2014 | 83.64% |
| Mar 31, 2014 | 17.86% |
| Dec 31, 2013 | -44.44% |
| Sep 30, 2013 | -44.12% |
| Jun 30, 2013 | 11.08% |
| Mar 31, 2013 | 12.78% |
| Dec 31, 2012 | 1,465.22% |
| Sep 30, 2012 | -94.12% |
| Jun 30, 2012 | 165.99% |
| Mar 31, 2012 | 107.98% |
| Dec 31, 2011 | -326.72% |
| Sep 30, 2011 | -33.33% |
| Jun 30, 2011 | -60.34% |